Sareum Holdings Plc - Product Pipeline Review - 2016


Posted April 13, 2017 by Shirley

MarketResearchReportStore adds "Sareum Holdings Plc - Product Pipeline Review - 2016" latest studies, published in March 2017. It is a professional and in-depth study on the current state.

 
MarketResearchReportStore adds "Sareum Holdings Plc - Product Pipeline Review - 2016" latest studies, published in March 2017. It is a professional and in-depth study on the current state.

For a sample of this report, please email at: [email protected]

Description
Summary
‘Sareum Holdings Plc - Product Pipeline Review - 2016’, provides an overview of the Sareum Holdings Plc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sareum Holdings Plc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from The proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Sareum Holdings Plc
- The report provides overview of Sareum Holdings Plc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Sareum Holdings Plc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Sareum Holdings Plc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Request Sample Copy, please email at: [email protected]

Table Of Contents
Sareum Holdings Plc Snapshot 6
Sareum Holdings Plc Overview 6
Key Facts 6
Sareum Holdings Plc - Research and Development Overview 7
Key Therapeutic Areas 7
Sareum Holdings Plc - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
Sareum Holdings Plc - Pipeline Products Glance 14
Sareum Holdings Plc - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Sareum Holdings Plc - Drug Profiles 16
CCT-244747 - Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
SAR-020106 - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
SAR-20347 - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
SAR-3 - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
SAR-4 - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
SART-1 - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
SART-29 - Drug Profile 26

Browse Complete Report with TOC @
https://www.marketresearchreportstore.com/shop/sareum-holdings-plc-product-pipeline-review-2016

For report sample or more information, please feel free to contact us:
Shirley | Sales Director
Call: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Us
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Marketing , Reports
Last Updated April 13, 2017